In a phase 1 clinical trial in patients with various types of tumors, the team gave doses of the targeted nanoparticles four times over 21 days in a 30-minute intravenous infusion.
在对罹患不同类型肿瘤患者进行临床试验的第一阶段，研究小组在21天内用30分钟静脉输液的形式给患者施用了四次针对性纳米粒子剂量。
In a phase 1 clinical trial in patients with various types of tumors, the team gave doses of the targeted nanoparticles four times over 21 days in a 30-minute intravenous infusion.
在对罹患不同类型肿瘤患者进行临床试验的第一阶段，研究小组在21天内用30分钟静脉输液的形式给患者施用了四次针对性纳米粒子剂量。
应用推荐